As shown in Fig. 5H-I, the HCC risk scores presented significant positive correlations with  the proliferation marker MKI67, and two immune check point genes PD1 (PDCD1) and CTLA4. This evidence concerns the gene CTLA4 and hepatocellular carcinoma.